GleamWall
中文EN

CC Chemours Co

Chemicals & Allied Products · NYSE · SEC CIK 1627223 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY0.1%
TTM net income YoY56.0%
TTM EPS YoY56.2%
Revenue 3-yr CAGR-1.2%
Net income 3-yr CAGR—

Margins

Gross margin15.2%
Operating margin—
Net margin-2.6%
FCF margin3.6%
EBITDA margin—

Returns

ROE-71.8%
ROA-2.1%
ROIC (approx.)—
Asset turnover0.79x

Leverage & solvency

Liabilities / assets97.9%
Debt / equity24.73x
Current ratio1.81x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-2.60x
Accruals ratio-7.5%
Payout ratio—
Capex / revenue3.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q42025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$1.54B$1.59B$1.38B$1.33B$1.50B$1.61B$1.37B$1.36B
Cost of revenue$1.31B$1.30B$1.17B$1.17B$1.26B$1.34B$1.13B$1.09B
Gross profit$231.00M$286.00M$212.00M$156.00M$233.00M$278.00M$236.00M$265.00M
R&D expense$24.00M$27.00M$26.00M$27.00M$26.00M$28.00M$27.00M$26.00M
SG&A expense—$469.00M$147.00M$130.00M$122.00M$424.00M$123.00M$170.00M
Interest expense$69.00M$68.00M$69.00M$68.00M$68.00M$67.00M$66.00M$67.00M
Pretax income$222.00M-$1.00M-$22.00M-$67.00M$38.00M-$248.00M$0$1.00M
Income tax$26.00M$273.00M$7.00M-$5.00M-$8.00M$131.00M$5.00M$12.00M
Net income$196.00M-$274.00M-$29.00M-$47.00M$46.00M-$380.00M-$5.00M-$11.00M
EPS (basic)1.29-1.81-0.19-0.310.31-2.53-0.03-0.08
EPS (diluted)1.29-1.81-0.19-0.310.31-2.53-0.03-0.08
Dividends declared per share0.090.090.090.090.090.090.250.25
Weighted avg. shares (diluted)151.91M151.23M150.77M—150.78M150.24M149.92M—
Balance sheet
Cash & equivalents$698.00M$671.00M$563.00M$670.00M$665.00M$553.00M$514.00M$763.00M
Receivables$765.00M$773.00M$645.00M$562.00M$817.00M$813.00M$704.00M$619.00M
Inventory$1.48B$1.45B$1.54B$1.57B$1.55B$1.56B$1.55B$1.46B
Current assets$3.22B$3.09B$2.93B$3.00B$3.21B$3.10B$2.93B$3.02B
PP&E, net$3.00B$3.03B$3.04B$3.08B$3.10B$3.13B$3.14B$3.19B
Goodwill$46.00M$46.00M$46.00M$46.00M$46.00M$46.00M$46.00M$46.00M
Intangibles———$2.00M$2.00M——$3.00M
Total assets$7.29B$7.15B$7.27B$7.38B$7.55B$7.46B$7.38B$7.51B
Current liabilities$1.78B$1.86B$1.61B$1.69B$1.87B$1.83B$1.67B$1.82B
Short-term debt$50.00M$34.00M$37.00M$42.00M$52.00M$38.00M$43.00M$54.00M
Long-term debt$3.78B$3.84B$4.10B$4.10B$4.10B$4.11B$4.07B$4.06B
Total debt$3.83B$3.87B$4.14B$4.14B$4.16B$4.15B$4.11B$4.11B
Total liabilities$7.14B$7.20B$7.05B$7.13B$7.27B$7.23B$6.81B$6.94B
Shareholders' equity$155.00M-$49.00M$215.00M$250.00M$274.00M$228.00M$566.00M$571.00M
Net debt$3.13B$3.20B$3.57B$3.47B$3.49B$3.59B$3.60B$3.35B
Shares outstanding150.52M150.46M150.36M149.89M149.87M149.70M149.57M149.43M
Cash flow statement
Operating cash flow$149.00M$158.00M-$44.00M$137.00M$146.00M$93.00M-$112.00M$138.00M
Capital expenditure$51.00M$44.00M$49.00M$45.00M$41.00M$43.00M$84.00M$109.00M
Free cash flow$98.00M$114.00M-$93.00M$92.00M$105.00M$50.00M-$196.00M$29.00M
Investing cash flow-$7.00M$239.00M-$44.00M-$43.00M-$35.00M-$42.00M-$86.00M-$107.00M
Financing cash flow-$63.00M-$289.00M-$19.00M-$37.00M-$5.00M-$27.00M-$57.00M$85.00M
Depreciation & amortization$79.00M$80.00M$79.00M$81.00M$80.00M$91.00M$88.00M$74.00M
Stock-based compensation$4.00M$7.00M$7.00M$4.00M$5.00M$7.00M$5.00M$3.00M
Dividends paid$13.00M$13.00M$13.00M$15.00M$13.00M$13.00M$37.00M$36.00M

Free plan shows the latest 8 periods; Pro shows all 51 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.